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An excretory function has been attributed to the salivary glands for a number of years. The composition of saliva has been shown to reflect the presence of certain substances in the blood, such as antibodies, blood-grouping substances, inorganic ions, and serum proteins. Recently, Schein and Tung (5) reported the passage of foreign proteins from the circulating blood to the whole saliva. Radioactive labeled human albumin was injected intravenously into either rabbits or humans, and after 3 hr the labeled protein could be recovered in the whole saliva of the subjects. The albumin crossed the blood barrier and passed into the saliva. The limits of this excretory function of saliva have never been outlined, and the size of a particle that can be excreted into the saliva has not yet been determined. Viruses, on the other hand, have been shown to pass a number of tissue barriers such as skin (2) , placenta (7) , and through the kidney into the urine (3, 6 4 kg. The inoculum varied in concentration from 103 to 10' TCID5o depending on the experiment. Saliva and blood samples were taken before initiating the viremia and at varying intervals thereafter. Unstimulated saliva samples were taken by swabbing the mouth of the animal with a cottontipped applicator. The applicator was then washed in 1 ml of maintenance medium. Blood samples from rabbits were taken from the marginal ear vein opposite to the ear used for inoculation. The blood was allowed to clot, and the serum fraction was collected by centrifugation. The serum and maintenance medium were then frozen and stored at -70 C for virus isolation.
Stimulated saliva. To quantitate the excretion of virus, it was necessary to collect at least 1 ml of saliva. Saliva was collected by using pilocarpine nitrate as a salivary gland stimulant. In all experiments, a dosage of 1.5 mg per kg of body weight was administered intravenously. Whole saliva was aseptically collected in a clean petri dish as it flowed directly from the mouth. Blood specimens were collected in the same manner as in the experiments with unstimulated saliva. All specimens were stored in the frozen state at -70 C.
Virus isolation. All viral isolations were carried out with the use of human epidermoid carcinoma (HEp-2) tissue culture monolayers with a maintenance medium of 2% calf serum in BME with Hank's balanced salt solution and fortified with 200 units per ml of penicillin, 200 ,ug/ml of streptomycin, and 5 g.g/ ml of amphotericin B. Each of two tubes of HEp-2 monolayers was inoculated with 0.1 ml of serum. (4) .
In the initial experiments, the virus recovered from the saliva was identified as the same virus injected intravenously by characterization with specific antisera against Coxsackie B-1. The antisera were prepared from rabbits inoculated with the same strain of virus used to initiate the viremias. required before a viremia could be detected at 60
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min. An inoculum of 107 TCID50 was required before virus could be detected in the saliva at 30 min. All viruses recovered from the saliva were neutralized by antisera against Coxsackie B-1. It was previously determined that an inoculum of 107 TCID5t will give a blood titer of approximately 104-5 TCIDso per 0.1 ml after 30 min. Therefore, it can be approximated that virus was excreted into the saliva when the blood titer was at least 104-5 TCID5o per 0.1 ml. An accurate determination of the relationship between the blood titer and the salivary titer can be seen in Fig. 1 . The salivary titer increased with the blood on October 11, 2017 by guest http://aem.asm.org/ Downloaded from titer. Between 104 TCID5o per 0.1 ml and 105.2 TCID50 per 0.1 ml, the saliva titer increased only slightly as compared with the increase in serum titer. After 105-5 TCID5o per 0.1 ml, the increase in salivary titer was more pronounced. A blood titer of between 103.6 and 104 TCID5o per 0.1 ml was required to recover virus in the saliva. A smaller blood titer was necessary to detect the presence of virus in the saliva than was observed in the unstimulated saliva experiments. This may be because the quantity of saliva assayed with stimulated saliva was greater and the chances for viral isolation were increased. Figure 2 shows the time course of blood and saliva titers. The blood titer remained constant throughout the 40-min period. Virus was recovered in the saliva as early as 2 min after injection of the virus into the ear vein of the rabbit. The salivary titer rises to a peak at about 16 min and then falls. DIscussIoN These results have shown that blood-borne Coxsackie B-1 virus in the rabbit is excreted into the saliva in less than 2 min after the establishment of a viremia of approximately 104 TCID50 per 0.1 ml. Coxsackie B-1 virus is not infective for the rabbit, and the virus need only be present in the blood for less than 2 min. There appears to be a physical passage of the virus from the blood to the saliva, and the virus is not present in the saliva as a result of an infective process. In the present study, all viral isolations were made from the whole saliva. Two possible methods of transmission of the virus from the blood to the saliva exist: the virus may pass from the blood through the salivary glands into the oral cavity, and the virus may pass from the blood stream across other structures in the oral cavity such as the oral mucosa or the periodontal membrane. Both of these methods of transmission are being investigated.
Larkin and Schultz (3) reported the recovery of Coxsackie B-1 virus from the urine of dogs whenever there was a serum titer of at least 102 TCID50 per 0.1 ml. A urine titer of 10'5 TCID5o per 0.1 ml was recovered when there existed a viremia of 103-TCID5o per 0.1 ml. The recovery of virus was accomplished as early as 3 min after the initiation of the viremia. The results of the present study with saliva are in agreement with this passage of virus to the urine, except that more virus was recovered from the urine by Larkin and Schultz, and a higher serum titer was required before virus could be detected in the saliva in the present study. These differences may be due to the homogeneous nature of urine as compared with the heterogeneous nature of whole saliva. Whole saliva is a mixture of a number of different capacities for virus excretion.
It seems logical that this process must occur in the infected animal since we have demonstrated that it occurs in the uninfected animal. A virus, if it is similar to Coxsackie B-1, may pass from the blood stream into the saliva during the viremic phase of an infection. Experimental infections in monkeys with virulent poliovirus have yielded viremias with viral titers as high as 107 TCIDio) per ml (1). Poliovirus is related to Coxsackie virus in size and other infective characteristics. This titer of viremia is well within the minimal range for the recovery of virus in the saliva. Saliva is a bacterial and viral vectoring medium in the transmission of viral infection by aerosol or through contamination of inanimate objects. Since the viremic phase of virus infection occurs primarily prior to overt clinical symptoms, the patient and physician are not aware of illness and therefore do not attempt to control the spread of infection. In view of these findings saliva may play a more important role in the epidemiology of virus infection.
